SelectScience InterviewsLife Sciences
Dr. Kevin Pfleger Discusses Novel nanoBRET Assay Development for High Throughput Screening
6 Nov 2017
Dr. Kevin Pfleger, Associate Professor at the University of Western Australia and Head of Molecular Endocrinology and Pharmacology at Harry Perkins Institute of Medical Research, discusses a recently published, novel nanoBRET assay that was developed in collaboration with BMG Labtech and Promega.
About the company

SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.






















